Amerise Biosciences (BOM:531681) Other Current Receivables: ₹0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531681 Amerise Biosciences Ltd BOM:531681
34 GF Score
Price ₹0.86
View Full Analysis

What is Amerise Biosciences Other Current Receivables?

Amerise Biosciences BOM:531681 +4.88% 34 Other Current Receivables is ₹0.00 Mil as of Jun. 2026. GuruFocus rates BOM:531681 with a GF Score™ of 34/100.

Amerise Biosciences's Other Current Receivables for the quarter that ended in Jun. 2026 was ₹0.00 Mil.

Amerise Biosciences Other Current Receivables Related Terms

Amerise Biosciences Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Amerise Biosciences's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amerise Biosciences Other Current Receivables Chart

Amerise Biosciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Amerise Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:531681
34GF Score
Amerise Biosciences Ltd BOM:531681
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amerise Biosciences Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹0.00 Mil mean?
Amerise Biosciences (BOM:531681) has a Other Current Receivables of ₹0.00 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Amerise Biosciences and its competitors.
Is Amerise Biosciences' Other Current Receivables too high?
Amerise Biosciences' current Other Current Receivables is ₹0.00 Mil. Overall, Amerise Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Amerise Biosciences' Other Current Receivables compare to CCXI and DMII?
Amerise Biosciences' Other Current Receivables of ₹0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Diversified Financial Services company?
A good Other Current Receivables depends on the Diversified Financial Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Amerise Biosciences and its competitors. Amerise Biosciences's current Other Current Receivables is ₹0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amerise Biosciences stock overvalued right now?
Amerise Biosciences (BOM:531681) has a current Other Current Receivables of ₹0.00 Mil. The current Other Current Receivables is ₹0.00 Mil. Amerise Biosciences' overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Amerise Biosciences (BOM:531681), the current Other Current Receivables is ₹0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amerise Biosciences Business Description

Address Navjeevan Press Road, 24, Laxmi Chambers, Opposite Old Gujarat High Court, Ahmedabad, GJ, IND, 380014
Amerise Biosciences Ltd is an Indian company which is not involved in any business activity.
34GF Score

Get the complete analysis for BOM:531681

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.86
Price